CTOs on the Move

Lasergen

www.lasergen.com

 
Lasergen is an emerging biotechnology company focused on commercializing novel technologies for DNA sequencing. Our expertise in nucleotide chemistry and next-generation sequencing has led to a number of key discoveries resulting in both game-changing sequencing chemistry (Lightning Terminators™) and a more accurate sequencing platform. While focusing on the development of current cutting-edge technology, our continued drive for innovation and extensive sequencing knowledge allows us to rapidly evolve and keep pace with fast-changing advances in the sequencing industry.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Lasergen raised $80M on 03/07/2016

Similar Companies

Advance Medical Designs Inc

Advance Medical Designs Inc is a Marietta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medtech Surgical Inc

Medtech Surgical Inc is a Newark, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Semler Scientific

Semler Scientific, Inc. is an emerging medical risk-assessment company whose diagnostic and testing products and services help to guide patient care and close the gap between cost of care and compensation for care.

Green Light Laser Therapy

Laserscope designs, manufactures, sells and services, on a worldwide basis, a line of medical laser systems and related energy delivery devices for the medical office, outpatient surgical center and hospital markets. It develops and commercializes

Biomet

Biomet, Inc. is one of the world's leading medical device manufacturers located in the Warsaw, Indiana business cluster. The company specializes in reconstructive products for hips, knees and shoulders, fixation devices, orthopedic support devices, dental implants, spinal implants and operating room supplies.   Biomet was established in 1977 and delivered its first hip replacement in 1978. In a September 2007 club deal the company was acquired by a consortium of private equity firms and ceased trading on NASDAQ.